Torigen Pharmaceuticals
Farmington
About Torigen Pharmaceuticals
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation. The company was founded in 2013 by Ashley Kalinauskas and Mark Suckow and is based in Farmington, Connecticut, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.1M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2022)
- Website: torigen.com
- Phone: 860-519-9956
Industries & Categories
Biotechnology, Health Care, Oncology, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/torigen-pharmaceuticals-35119 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.